» Articles » PMID: 23741239

Systemic Epstein-Barr Virus-positive T-cell Lymphoproliferative Disease of Childhood: Report of a Case with Review of the Literature

Overview
Journal Oncol Lett
Specialty Oncology
Date 2013 Jun 7
PMID 23741239
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disease (LPD) of childhood is an extremely rare and distinct clinicopathological entity. The majority of these cases occur with an apparent primary EBV infection. In this study, we describe a case of systemic EBV-positive T-cell LPD of childhood in a 23-year-old female with primary EBV infection, and review the clinicopathological features of this disease. A 23-year-old previously healthy female without an immunocompromized status presented with an acute onset of high fever. Laboratory examinations revealed a markedly elevated white blood cell count and liver and renal function. Peripheral blood smears identified a number of atypical lymphocytes with small azurophilic granules in the cytoplasm. Bone marrow aspiration revealed marked proliferation of small-sized lymphocytes with convoluted nuclei, which expressed EBER1, CD3, CD8 and cytotoxic granules. Monoclonal rearrangements of T-cell receptors were also detected. The patient underwent chemotherapy, but succumbed to multiorgan failure 20 weeks after administration. Upon review of 17 cases of this disease, including the one in the present study, we identified that the major clinicopathological features of systemic EBV-positive T-cell LPD of childhood are as follows: i) clonal systemic proliferation of EBV-infected T-cells that appear morphologically innocuous with an activated cytotoxic phenotype; ii) a high prevalence in the Asian population, commonly affecting children and young adults; iii) a predilection for males; iv) most commonly involved sites are the liver, spleen, lymph node and bone marrow, and the main clinical presentations are hepatosplenomegaly, fever and pancytopenia; v) almost all cases have an aggressive clinical course, which results in mortality. Cytological atypia of the neoplastic cells in this disease, as observed in the present case, is minimal. This study revealed that the cytomorphological features of atypical lymphocytes in the peripheral blood are indistinguishable from those of infectious mononucleosis.

Citing Articles

Epstein-Barr Virus-Driven T-Cell Lymphoma with Haemophagocytic Lymphohistiocytosis: A Life-Threatening Disorder Extending Beyond Childhood.

Wannaphut C, Kozai L, Takahashi T, Macapagal S, Nishimura Y Eur J Case Rep Intern Med. 2024; 11(11):004931.

PMID: 39525447 PMC: 11542956. DOI: 10.12890/2024_004931.


Case Report: Primary Indolent Epstein-Barr Virus-Positive T-Cell Lymphoproliferative Disease Involving the Central Nervous System.

Wang K, Li J, Zhou X, Lv J, Wang Y, Li X Front Surg. 2022; 9:775185.

PMID: 35310431 PMC: 8929129. DOI: 10.3389/fsurg.2022.775185.


Epstein-Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features.

Syrykh C, Pericart S, Lamaison C, Escudie F, Brousset P, Laurent C Cancers (Basel). 2021; 13(13).

PMID: 34282778 PMC: 8268319. DOI: 10.3390/cancers13133315.


Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.

Wada S, Suzuki T, Kitazume K, Fujita A, Shimizu S Int J Hematol. 2017; 108(1):112-117.

PMID: 29218495 DOI: 10.1007/s12185-017-2380-4.


Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.

Chen G, Chen L, Qin X, Huang Z, Xie X, Li G Int J Clin Exp Pathol. 2014; 7(10):7110-3.

PMID: 25400806 PMC: 4230111.


References
1.
Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma D . Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000; 96(2):443-51. View

2.
Noma T, Kou K, Yoshizawa I, Kawano Y, Miyashita T, Mizutani S . Monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome. Eur J Pediatr. 1994; 153(10):734-8. DOI: 10.1007/BF01954490. View

3.
Ohshima K, Kimura H, Yoshino T, Kim C, Ko Y, Lee S . Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008; 58(4):209-17. DOI: 10.1111/j.1440-1827.2008.02213.x. View

4.
Su I, Lin K, Chen C, Tien H, Hsieh H, Lin D . Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype. Cancer. 1990; 66(12):2557-62. DOI: 10.1002/1097-0142(19901215)66:12<2557::aid-cncr2820661218>3.0.co;2-2. View

5.
Mori M, Kurozumi H, Akagi K, Tanaka Y, Imai S, OSATO T . Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. N Engl J Med. 1992; 327(1):58. DOI: 10.1056/NEJM199207023270118. View